The Scientific Advisory Group (SAG) to Convene to Discuss the Marketing Authorization Application for lecanemab in the EU Source Cluster: JCN Newswire Source Node: 3055478Time Stamp: Jan 11, 2024
“LEQEMBI Intravenous Infusion”Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20 Source Cluster: JCN Newswire Source Node: 3016216Time Stamp: Dec 14, 2023
Scientists Unearth Brand New Links Between Genes and Disease in Our Blood Source Cluster: Singularity Hub Source Node: 2921685Time Stamp: Oct 6, 2023
“LEQEMBI Intravenous Infusion” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan Source Cluster: JCN Newswire Source Node: 2900792Time Stamp: Sep 25, 2023
Week Ahead – Bracing for next week’s earnings, rate decisions, and major economic data – MarketPulse Source Cluster: MarketPulse Source Node: 2777123Time Stamp: Jul 21, 2023
SpicyIP Weekly Review (May 15- May 20) Source Cluster: Spicy IP Source Node: 2670182Time Stamp: May 22, 2023
Biogen Owes Patent Royalties For MS Drug, Genentech Says Source Cluster: Law 360 Source Node: 1987341Time Stamp: Mar 1, 2023
Week Ahead – A valentine’s day treat Source Cluster: MarketPulse Source Node: 1951703Time Stamp: Feb 10, 2023
Stocks rally as BOE intervenes, promising news from Biogen, bitcoin Source Cluster: MarketPulse Source Node: 1701615Time Stamp: Sep 28, 2022